Mark Edelstein

26 papers receiving 289 citations

Peers

Mark Edelstein
Comparison fields: 5 of 55
  • Hematology 54
  • Cancer Research 54
  • Genetics 36
  • Oncology 83
  • Pathology and Forensic Medicine 39
Replace M.J. Tilby with:
M.J. Tilby United Kingdom
Patricia A. Toniolo United States
Martine B.W. Prinsen Netherlands
Murray Yule United States
Sueo Mukumoto Japan
Mai Itoh Japan
Yangxin Fu Canada
Jennifer S. Hackbarth United States
R.G. Fish United Kingdom
Mark Edelstein relative to M.J. Tilby United Kingdom M.J. Tilby's profile →
Citations per field
00.5×1.5×2.3×
M.J. Tilby · 1×
Citations per year

Countries citing papers authored by Mark Edelstein

Since Specialization
Citations

This map shows the geographic impact of Mark Edelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Edelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Edelstein more than expected).

Fields of papers citing papers by Mark Edelstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Edelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Edelstein. The network helps show where Mark Edelstein may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Edelstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Edelstein Line = papers co-authored together Mark Edelstein links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1 200247
2
Schedule-dependent synergism for the combination of 1-beta-D-arabinofuranosylcytosine and daunorubicin.
197438
3 198336
4
The enhanced cytotoxicity of combinations of 1-beta-D-arabinofuranosylcytosine and methotrexate.
197528
5 199724
6
In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells.
198923
7 198421
8 199621
9 197721
10 19838
11 19787
12 19855
13 19895
14 19865
15 19865
16
Biological aspects of the subrenal capsule assay of importance in the screening of cytostatic agents.
19844
17
Combined effect of cytosine arabinoside and thiopurines.
19764
18
Specificity, schedule, and proliferation dependence of infused L-histidinol after 5-fluorouracil in mice.
19884
19 19903
20 19772

About Mark Edelstein

Mark Edelstein is a scholar working on Molecular Biology, Oncology, Hematology, Public Health, Environmental and Occupational Health and Genetics, having authored 27 papers that have together received 321 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (4 papers), DNA Repair Mechanisms (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Cancer therapeutics and mechanisms (3 papers), Effects of Radiation Exposure (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Biochemical and Molecular Research (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Hematology (54 citations), Cancer Research (54 citations), Genetics (36 citations), Oncology (83 citations) and Pathology and Forensic Medicine (39 citations). Mark Edelstein has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Teresa J. Vietti, Fred Valeriote, Frederick A. Valeriote, L. M. van Putten, Heinz H. Fiebig, Thomas H. Corbett, Laurence H. Baker, Michael Bischoff, K. Van Cauwenberghe and Sandra Biggar. Their work appears in journals such as Cancer Investigation, JNCI Journal of the National Cancer Institute, Biochemical Pharmacology, Investigational New Drugs and The American Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact